(NYSE:PSN), CHANTILLY, Va., Dec. 18, 2025 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE:PSN) has named proven executive and legal expert John Martinez as the company's next chief legal officer (CLO), effective February 16, 2026. The announcement follows the notification by current CLO Mike Kolloway to Parsons' CEO and board of directors of his intent to retire […]
(NASDAQ:VTVT), HIGH POINT, N.C., Dec. 18, 2025 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced a Phase 2 clinical study protocol developed in collaboration with M42's Insights Research Organization & Solutions (IROS), a leading United Arab Emirates (UAE)-based contract research organization, has been submitted to the Department of Health
(NASDAQ:HFFG), POWDER SPRINGS, Ga., Dec. 18, 2025 (GLOBE NEWSWIRE) — HF Foods Group (Nasdaq: HFFG) (“HF Foods” or the “Company”), a leading distributor of international foodservice solutions to Asian restaurants and other businesses across the United States, celebrated the opening of its newest distribution center just outside of Atlanta, GA in the City of Powder
(Paris:ABVX),(NasdaqGM:ABVX), Abivax to be Added to Nasdaq Biotechnology Index PARIS, France – December 18, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in
Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment GlobeNewswire December 18, 2025 MOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI
Applied Digital Sets Fiscal Second Quarter 2026 Conference Call for Wednesday, January 7, 2026, at 5:00 p.m. Eastern Time GlobeNewswire December 18, 2025 DALLAS, Dec. 18, 2025 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocations services for
Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire December 18, 2025 NORTHFIELD, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) — Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized initial public offering of 248,439,654 shares of its Class A common stock
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 18, 2025 SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on
Mission Produce(R) Announces Leadership Succession and Provides Update on Board Refreshment Initiative GlobeNewswire December 18, 2025 Founder & CEO Steve Barnard to Transition to Executive Chairman of the Board; President and COO John Pawlowski to Become CEO at the close of the Annual Meeting of Shareholders in April 2026 Board Refreshment Initiative Underway -Three New
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 18, 2025 CONSHOHOCKEN, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on December 15, 2025 to 4 new